Thanks

I thought Dr Huan was bad it’s so much worse now. No more EUAs for Covid ect this Alzheimer’s approval is a mess. She’s is worthless.

Still here, what could we expect Monday ?

Disagree we will be trading double digits once Nash is out.

NP is here to stay thank god.

Bruce Patterson said he would be CMO and that the new CEO would sell the company

Is this true ? I’ll take a peak but I’m interested now.

Well said

Really ?!

Price target for the next 3 months ??
My guess is 30.

100 million market cap seems about right.

When do we think full enrollment will be?

Wow

Is this a serious post ? You know a lot of your information isn’t accurate right ?

As always I enjoy your post and continue to but the dips here.

So let’s say end of the year it’s done how long for the actual data ?

First Q 2021 ?! I’m buying the dips

Got it thank you !

SLS

Buy after hours going to take off on the 3rd like PDSB.

Good luck

Same

Gotcha yea just noticed.

Gotcha same!

What happened to Fress ?

Gotcha

Ugh yea I thought for sure this would slow down lol how high can this go seriously?

Lol that would be nice

I sold some but I’m playing with almost al house money and don’t plan on selling anytime soon.

https://ca.proactiveinvestors.com/companies/news/914225/pds-biotech-preparing-to-initiate-three-phase-two-clinical-studies-for-lead-candidate-pds0101-in-partnership-with-leading-oncology-institutions-914225.html

Owe all of you. Any other plays soon?
My only other one coming soon I mentioned. Always looking for others !

Jeez look at it go
Wish I owned more!

Good call over here officially up over 100 percent !

Take a look at SLS. Sounds like the will be getting some data out soon!

Jeez this thing just keeps going lol

Agree I’m not going to lie sold some today but I’m playing with only house money now. I may increase my position but in the short term I’m looking at SLS for their phase 3 data peak on June 3rd.

Any news on the next thing that will make this pop !?

No trust me I was thinking it before you said it. I invest only in bio stocks and not to toot my own horn but I’m pretty good at it. I will be buying more again but moved money around a little.

This is a long hold. I’m glad I got in a few weeks back thanks to your DD.

No agree but I always de risk now I’ve had hard lessons. Sold a little playing with mostly house money now.

My question as well ? Was going to sell some buy it’s showing no sign of a correct yet.

My question Whats your price target after the data.

Have to de risk soon here since I’m almost up 100 percent.

Price predictions?

This is good news correct ?

Seems like we could soar tmw

Offering is out? Isn’t it like 50 for 1 million shares ?

https://seekingalpha.com/article/4430722-annovis-bio-positive-alzheimers-data-strengthens-bullish-thesis

Price target for Monday ?
I hit the sell on some but have plenty left

You are comparing a Phase 3 to a phase 2 and talking about two completely different goals and patient population. I’m not even going to continue with this....

How many patients did SAVA have enrolled with their phase two. That’s right 25 and they are worth 1.5 billon and their results aren’t ground breaking. Its a phase 2 not a 3 so please spare me with the numbers.

IMO Biogen just got out on notice after these results.

You are inaccurate. First of all they have more data on the 27th also with Alzheimer’s your goal is to look at data past the 25 days. More like 6 months...

It beat SAVA data at their 25 day mark if you read the abstract.

At 6 months they will have a much better P value.

I’m invested in several AD stocks. I don’t know how anyone here can argue the data so far is bad. If so you should invest in AD stocks or bio stocks.

The bar is very low for AD at this point and so far ANVS has the best data at 25 days. Assuming AD will get worse in placebo they should have better data then SAVA at 6 months.

The FDA will grant a phase 3 IMO.

also only at day 25, it is possible a longer duration may improve cognition further, making the placebo effect less significant and improving the p-score

while the placebo controlled group didn't reach statistical significance, it came close. I believe that is why they reported the baseline comparision as well... it is possible that the placebo effect could be reduced through better screening, trial modification or it may become a non-issue as more data comes in. Overall i like the chances on this one